A Lifeline for Alpha-Gal Patients Is at Risk

On Martha’s Vineyard, we’ve become all too familiar with ticks and the conditions they cause—including alpha-gal syndrome (AGS), a life-altering allergy to mammalian products triggered by tick bites.

For many people with AGS, the challenge goes beyond diet. Medications themselves can contain mammalian-derived ingredients — such as gelatin capsules, fillers and stabilizers. Yet there is currently no requirement by the U.S. Food and Drug Administration to clearly disclose the source of ingredients in medications.

That leaves patients, pharmacists and clinicians in an impossible position: how do you safely take or prescribe a medication when you can’t reliably determine what’s in it?

This is where Pill Clarity comes in.

Pill Clarity is a four-person nonprofit team of pharmacists and health practitioners providing an essential, highly specialized service nationwide. Their team engages directly with manufacturers to determine whether medications contain mammalian-derived ingredients, track formulation changes and maintain a growing database of medication safety information.

Because ingredients and sourcing can change, this work is continuous and critical. Demand for these services are accelerating, and its role in patient safety is becoming increasingly evident. For the estimated 450,000 Americans living with AGS nationwide — and the providers who care for them — Pill Clarity is a lifeline.

Here on the Vineyard, Pill Clarity is a standard resource we share with the community. It allows clinicians to prescribe with confidence, helps pharmacists counsel safely and most importantly, helps patients avoid serious — even life-threatening — reactions. And they do all of this for free. But now, that lifeline is at risk.

Pill Clarity operates almost entirely on voluntary contributions and is currently facing the possibility of shutting down within months. We cannot afford to lose this resource.

In the long term, transparency around medication ingredients should be a standard, regulated function of our healthcare system. Until that happens, Pill Clarity is filling a gap that no one else is addressing. This is a moment where community support matters.

If you believe patients and providers deserve clear, accessible information about what’s in medications, I urge you to learn more about Pill Clarity and consider supporting their work. Because right now, they are holding together a system that should already exist. And losing them would leave patients without a safety net.

Lea Hamner is an epidemiologist working with the Martha’s Vineyard Tick Program and the Inter-Island Public Health Excellence Collaborative, a coalition of all the Island towns. She lives in Chilmark.

This article appears in May 8, 2026.